Summary
UnitedHealth Group Inc. (UNH) reported a strong third quarter of 2022, demonstrating robust financial performance and continued growth across its business segments. Total revenues reached $80.9 billion, a 12% increase year-over-year, driven by significant growth in both the UnitedHealthcare and Optum segments. UnitedHealthcare saw an 11% revenue increase, serving approximately 910,000 more people, primarily in Medicare Advantage and Medicaid programs. The Optum segment exhibited even stronger growth, with revenues up 17%, reflecting the continued expansion of its health services offerings. Net earnings attributable to common shareholders increased by 29% to $5.3 billion for the quarter, resulting in diluted earnings per share of $5.55, up from $4.28 in the prior year. For the first nine months of 2022, net earnings grew 16% to $15.4 billion. The company's strong operational performance is supported by substantial cash flows from operations, which amounted to $30.7 billion for the nine-month period. Significant investments in strategic acquisitions, notably Change Healthcare and LHC Group, highlight the company's commitment to expanding its capabilities and market position.
Financial Highlights
54 data points| Revenue | $80.89B |
| Cost of Revenue | $8.31B |
| Gross Profit | $72.59B |
| SG&A Expenses | $11.66B |
| Operating Expenses | $73.43B |
| Operating Income | $7.46B |
| Interest Expense | $516.00M |
| Net Income | $5.26B |
| EPS (Basic) | $5.63 |
| EPS (Diluted) | $5.55 |
| Shares Outstanding (Basic) | 935.00M |
| Shares Outstanding (Diluted) | 948.00M |
Key Highlights
- 1Total revenues for the third quarter of 2022 grew 12% year-over-year to $80.9 billion.
- 2Net earnings attributable to common shareholders increased by 29% to $5.3 billion for the third quarter.
- 3Diluted earnings per share (EPS) rose to $5.55 for the quarter, up from $4.28 in the prior year.
- 4UnitedHealthcare served 910,000 more people, with significant growth in Medicare Advantage and Medicaid programs.
- 5Optum segment revenues increased by 17%, driven by strong performance across Optum Health, Insight, and Rx.
- 6Cash flows from operating activities for the nine months ended September 30, 2022, were robust at $30.7 billion.
- 7The company is proceeding with significant strategic acquisitions, including the recently completed Change Healthcare acquisition.